Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,532 | 20,579 | 10,760 | 12,817 | 13,162 |
| Marketable Securities | 50,203 | 51,614 | 32,715 | 37,482 | 42,587 |
| Receivables | 2,422 | 4,281 | 3,373 | 3,078 | 2,452 |
| TOTAL | $70,382 | $78,888 | $48,843 | $54,991 | $59,519 |
| Non-Current Assets | |||||
| PPE Net | 846 | 776 | 810 | 854 | 844 |
| Other Non-Current Assets | 49 | 49 | 133 | 232 | 139 |
| TOTAL | $895 | $825 | $943 | $1,086 | $983 |
| Total Assets | $71,277 | $79,713 | $49,786 | $56,077 | $60,502 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,077 | 952 | 763 | 389 | 615 |
| Accrued Expenses | 6,438 | 5,223 | 5,002 | 5,220 | 4,212 |
| TOTAL | $7,515 | $6,175 | $5,765 | $5,629 | $4,877 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 0 | N/A | N/A | 20 | 50 |
| Other Non-Current Liabilities | 81 | 91 | 101 | 111 | 117 |
| TOTAL | $81 | $91 | $101 | $111 | $117 |
| Total Liabilities | $7,596 | $6,266 | $5,866 | $5,740 | $4,994 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 958 | 880 | 874 | 669 | 666 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -101,963 | -90,046 | -80,632 | -72,513 | -66,030 |
| Other shareholders' equity | -33 | -56 | -98 | -102 | -32 |
| TOTAL | $63,681 | $73,447 | $43,920 | $50,337 | $55,508 |
| Total Liabilities And Equity | $71,277 | $79,713 | $49,786 | $56,077 | $60,502 |